Maplight Therapeutics Inc (MPLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Cash Flows From Operating Activities | ||
| Net Income | -161,152 | -77,580 |
| Depreciation Amortization | -1,524 | -1,040 |
| Accounts payable and accrued liabilities | 1,384 | -1,345 |
| Other Working Capital | -12,836 | -3,065 |
| Other Operating Activity | 35,991 | 4,215 |
| Operating Cash Flow | $-138,137 | $-78,815 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | -322,734 | -80,018 |
| PPE Investments | -473 | -770 |
| Investing Cash Flow | $-323,207 | $-80,788 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 275,716 | 294 |
| Other Financing Activity | 194,104 | 117,766 |
| Financing Cash Flow | $469,820 | $118,060 |
| Beginning Cash Position | 38,460 | 80,003 |
| End Cash Position | 46,936 | 38,460 |
| Net Cash Flow | $8,476 | $-41,543 |
| Free Cash Flow | ||
| Operating Cash Flow | -138,137 | -78,815 |
| Capital Expenditure | -473 | -770 |
| Free Cash Flow | -138,610 | -79,585 |